In conclusion, we found that 20(S)-Rg3 reversed EMT to inhibit ovarian cancer cells migration and invasion via antagonizing DNMT3A-mediated methylation of pre-miR-145 to promote inhibition of miR-145 on FSCN1. Here, DNMT3A is linked to ovarian cancer.